The announcement of Cardiff Oncology's Q1 financial results has led to a decrease in its stock price. Financial results are a key indicator of a company's health and future prospects, and the market's reaction suggests that the results may have not met investor expectations. This negative sentiment is likely to impact the stock's performance in the short term.